This month, the reauthorization of the America COMPETES Act became law. First passed in 2007, the America COMPETES Act provided funding for science agencies and research (see IBO 8/15/07). Although the new law specifies funding amounts for federal science agencies, it is unlikely that these amounts will be appropriated due to the new Congress that […]

In 2010, the US economy and equity markets sustained a strong recovery in the wake of the financial collapse two years ago. Following double-digit gains in 2009, the Dow Jones Industrial Average, S&P 500 and NASDAQ added 11.0%, 12.8% and 16.9% in 2010, respectively. Equity prices benefited from monetary stimulus, improving macroeconomic data, strong corporate […]

Due to the IBO’s January 15 forecast issue, third-quarter results for the Lab Equipment/Consumables Sales Index are included in this issue. Index sales grew 2.7%, 3.6% excluding currency, to $3,760.20 million. Operating profits improved 3.2% to $631.67 million, and adjusted operating margins were unchanged at 17.2% of sales. For the fiscal first quarter ending October […]

As detailed in the November 15 issue of IBO, an annual review by the EU showed that spending by 1,000 of the world’s largest publicly held companies that engage in substantial R&D activities declined last fiscal year. This month, the UK released its annual R&D spending review, which provided further evidence of the trends documented […]

Third-quarter 2010 IBO Life Science Index sales grew 7.2%, 8.5% excluding currency, to $2,944.55 million. Operating profit improved 11.5% to $636.50 million, and operating margin gained 110 basis points to 22.5% of sales. Third-quarter revenue for Beckman Coulter’s Life Sciences segment declined 5.1%, 4.1% at constant currency, to $106.1 million to account for 12% of […]

Despite drastic reductions in pharmaceutical R&D headcount and spending, which have reduced growth, flash chromatography, a preparative LC technique, accounted for more than $100 million in annual revenues in 2009 (see table, page 6) and is expected to grow in the mid-to-high single digits. Demand for flash chromatography comes mainly from the pharmaceutical, biotechnology and […]

In the second multibillion dollar acquisition this year involving a laboratory product and instrumentation company following the purchase of Millipore (see IBO 2/28/10), Thermo Fisher Scientific announced this month it will acquire Dionex for $2.1 billion in cash (see page 2), or approximately five times sales. This is Thermo’s largest acquisition since its 2006 purchase […]

Bruker BioSpin’s Icon scanner, introduced in September, provides a smaller, lower-cost system for MRI scanning for research. The Icon expands Bruker’s high-field preclinical and molecular MRI product line, which previously ranged from 4.7 to 17 T field strength, to lower-field (1 T) permanent-magnet benchtop MRI systems, said Director of Marketing Communications Thorsten Thiel. It is […]